Overview
Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore the latest advancements in Latent TB Infection diagnosis and treatment in this comprehensive physician grand rounds presentation. Delivered by Dr. Douglas Hornick from the University of Iowa Carver College of Medicine, the lecture covers crucial topics including refugee and immigrant TB screening, US vs. foreign-born TB cases, and the focus of TB control in the United States. Delve into TB nomenclature, pathogenesis, and disease progression, while examining the limitations of traditional skin tests. Learn about the upgraded Interferon Gamma Release Assay (IGRA) for LTBI testing and understand the tuberculosis screening flowchart. Gain insights into real-world dosing practices, safety issues related to INH treatment, and proper monitoring procedures for patients undergoing treatment. This comprehensive presentation provides essential knowledge for healthcare professionals dealing with latent TB infection management and control.
Syllabus
Intro
What's This?
Refugee & Immigrant TB Screening
US vs. Foreign-Born TB Cases 2016: 48 cases (34 Non-US)
Focus of TB Control in the US: Targeted Testing & Rx for LTBI
TB Nomenclature
TB Pathogenesis Progression to Disease
Limitations for TST
LTBI Testing Upgrade... Interferon Gamma Release Assay IGRA
Tuberculosis Screening Flowchart
Real World Dosing
Safety Issues for INH: Current Practice Outcomes
Monitoring on Treatment
Additional Summary Points
Taught by
Mary Greeley Medical Center